These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 21248297)
1. Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway. Hamano R; Miyata H; Yamasaki M; Kurokawa Y; Hara J; Moon JH; Nakajima K; Takiguchi S; Fujiwara Y; Mori M; Doki Y Clin Cancer Res; 2011 May; 17(9):3029-38. PubMed ID: 21248297 [TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced modification of microRNA expression in esophageal cancer. Hummel R; Wang T; Watson DI; Michael MZ; Van der Hoek M; Haier J; Hussey DJ Oncol Rep; 2011 Oct; 26(4):1011-7. PubMed ID: 21743970 [TBL] [Abstract][Full Text] [Related]
3. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. Sugimura K; Miyata H; Tanaka K; Hamano R; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y Clin Cancer Res; 2012 Sep; 18(18):5144-53. PubMed ID: 22847808 [TBL] [Abstract][Full Text] [Related]
4. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines. Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD. Chen Y; Ke G; Han D; Liang S; Yang G; Wu X Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997 [TBL] [Abstract][Full Text] [Related]
6. The activation of Akt during preoperative chemotherapy for esophageal cancer correlates with poor prognosis. Yoshioka A; Miyata H; Doki Y; Yasuda T; Yamasaki M; Motoori M; Okada K; Matsuyama J; Makari Y; Sohma I; Takiguchi S; Fujiwara Y; Monden M Oncol Rep; 2008 May; 19(5):1099-107. PubMed ID: 18425364 [TBL] [Abstract][Full Text] [Related]
7. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. Hong L; Han Y; Zhang H; Li M; Gong T; Sun L; Wu K; Zhao Q; Fan D Ann Surg; 2010 Jun; 251(6):1056-63. PubMed ID: 20485139 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Yang H; Kong W; He L; Zhao JJ; O'Donnell JD; Wang J; Wenham RM; Coppola D; Kruk PA; Nicosia SV; Cheng JQ Cancer Res; 2008 Jan; 68(2):425-33. PubMed ID: 18199536 [TBL] [Abstract][Full Text] [Related]
9. Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells. Fu X; Tian J; Zhang L; Chen Y; Hao Q FEBS Lett; 2012 May; 586(9):1279-86. PubMed ID: 22465665 [TBL] [Abstract][Full Text] [Related]
10. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Su L; Wang Y; Xiao M; Lin Y; Yu L Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995 [TBL] [Abstract][Full Text] [Related]
11. Role of microRNAs in drug-resistant ovarian cancer cells. Sorrentino A; Liu CG; Addario A; Peschle C; Scambia G; Ferlini C Gynecol Oncol; 2008 Dec; 111(3):478-86. PubMed ID: 18823650 [TBL] [Abstract][Full Text] [Related]
12. miR-27 is associated with chemoresistance in esophageal cancer through transformation of normal fibroblasts to cancer-associated fibroblasts. Tanaka K; Miyata H; Sugimura K; Fukuda S; Kanemura T; Yamashita K; Miyazaki Y; Takahashi T; Kurokawa Y; Yamasaki M; Wada H; Nakajima K; Takiguchi S; Mori M; Doki Y Carcinogenesis; 2015 Aug; 36(8):894-903. PubMed ID: 26026166 [TBL] [Abstract][Full Text] [Related]
13. miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells. van Jaarsveld MT; Helleman J; Boersma AW; van Kuijk PF; van Ijcken WF; Despierre E; Vergote I; Mathijssen RH; Berns EM; Verweij J; Pothof J; Wiemer EA Oncogene; 2013 Sep; 32(36):4284-93. PubMed ID: 23045278 [TBL] [Abstract][Full Text] [Related]
14. microRNA-10b confers cisplatin resistance by activating AKT/mTOR/P70S6K signaling via targeting PPARγ in esophageal cancer. Wu K; Hu Y; Yan K; Qi Y; Zhang C; Zhu D; Liu D; Zhao S J Cell Physiol; 2020 Feb; 235(2):1247-1258. PubMed ID: 31267531 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of Interleukin-6 suppresses cisplatin-induced cytotoxicity in esophageal squamous cell carcinoma cells. Suchi K; Fujiwara H; Okamura S; Okamura H; Umehara S; Todo M; Furutani A; Yoneda M; Shiozaki A; Kubota T; Ichikawa D; Okamoto K; Otsuji E Anticancer Res; 2011 Jan; 31(1):67-75. PubMed ID: 21273582 [TBL] [Abstract][Full Text] [Related]
16. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma. Iizuka N; Hirose K; Noma T; Hazama S; Tangoku A; Hayashi H; Abe T; Yamamoto K; Oka M Br J Cancer; 1999 Oct; 81(3):469-75. PubMed ID: 10507772 [TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis. Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173 [TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of the response of esophageal carcinoma cells to cisplatin. Takashima N; Ishiguro H; Kuwabara Y; Kimura M; Mitui A; Mori Y; Mori R; Tomoda K; Hamaguchi M; Ogawa R; Katada T; Harada K; Fujii Y Dis Esophagus; 2008; 21(3):230-5. PubMed ID: 18430104 [TBL] [Abstract][Full Text] [Related]
19. Noncoding RNA Expression Aberration Is Associated with Cancer Progression and Is a Potential Biomarker in Esophageal Squamous Cell Carcinoma. Sugihara H; Ishimoto T; Miyake K; Izumi D; Baba Y; Yoshida N; Watanabe M; Baba H Int J Mol Sci; 2015 Nov; 16(11):27824-34. PubMed ID: 26610479 [TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor 1 mediates 5-fluorouracil chemoresistance in esophageal carcinoma cells through increasing survivin stability. Juan HC; Tsai HT; Chang PH; Huang CY; Hu CP; Wong FH Apoptosis; 2011 Feb; 16(2):174-83. PubMed ID: 21082354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]